Asian Journal of Social Pharmacy
Asian Journal Of Social Pharmacy

Quick Search Year Search

Asian Journal of Social Pharmacy ›› 2020, Vol. 15 ›› Issue (2): 89-96.

Previous Articles     Next Articles

The Status Quo and Countermeasures of “4+7” Quantity Purchase in China

Zhou Yusheng, Wei Xingchen, Piao Huiling, Wang Nan, Wang Xing, Dong Li*   

  1. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
  • Online:2020-06-20 Published:2020-06-19
  • Contact: Dong Li, associate professor. Major research area: pharmaceutical intellectual property, pharmaceutical international trade research. Tel: 024-23986543, E-mail: sydongli@163.com. E-mail:sydongli@163.com

PDF

4312

Abstract: Objective To understand the effectiveness and problems of centralized drug procurement in China by analyzing the implementation of the “4+7” pilot work for centralized drug procurement in China. Methods The current situation and existing problems of drug procurement in China were analyzed through the literature research method. Results and Conclusion At present, good social benefits have been achieved for China’s drug procurement through pilot projects in several cities, but there are some serious problems. The proposed countermeasures will help to improve the procurement of pharmaceuticals in China.

Key words: quantity procurement, 4+7, drug bidding

Trendmd

Copyright © Asian Journal of Social Pharmacy

Supported by:Beijing Magtech